Kynurenines in the mammalian brain: when physiology meets pathology

R Schwarcz, JP Bruno, PJ Muchowski… - Nature Reviews …, 2012 - nature.com
The essential amino acid tryptophan is not only a precursor of serotonin but is also
degraded to several other neuroactive compounds, including kynurenic acid, 3 …

Kynurenines in the CNS: recent advances and new questions

L Vécsei, L Szalárdy, F Fülöp, J Toldi - Nature reviews Drug discovery, 2013 - nature.com
Various pathologies of the central nervous system (CNS) are accompanied by alterations in
tryptophan metabolism. The main metabolic route of tryptophan degradation is the …

Kynurenine pathway metabolites in humans: disease and healthy states

Y Chen, GJ Guillemin - International journal of tryptophan …, 2009 - journals.sagepub.com
Tryptophan is an essential amino acid that can be metabolised through different pathways, a
major route being the kynurenine pathway. The first enzyme of the pathway, indoleamine-2 …

Kynurenic acid in neurodegenerative disorders—Unique neuroprotection or double‐edged sword?

A Ostapiuk, EM Urbanska - CNS neuroscience & therapeutics, 2022 - Wiley Online Library
Aims The family of kynurenine pathway (KP) metabolites includes compounds produced
along two arms of the path and acting in clearly opposite ways. The equilibrium between …

The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders

TW Stone, LG Darlington - British journal of pharmacology, 2013 - Wiley Online Library
Understanding the neurochemical basis for cognitive function is one of the major goals of
neuroscience, with a potential impact on the diagnosis, prevention and treatment of a range …

Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites

F Moroni - European journal of pharmacology, 1999 - Elsevier
The synthesis of NAD (or NADP) from tryptophan involves a series of enzymes and the
formation of a number of intermediates which are collectively calledkynurenines.'In the late …

Kynurenines in the CNS: from endogenous obscurity to therapeutic importance

TW Stone - Progress in neurobiology, 2001 - Elsevier
In just under 20 years the kynurenine family of compounds has developed from a group of
obscure metabolites of the essential amino acid tryptophan into a source of intensive …

Presynaptic kynurenate‐sensitive receptors inhibit glutamate release

R Carpenedo, A Pittaluga, A Cozzi… - European Journal of …, 2001 - Wiley Online Library
Kynurenic acid is a tryptophan metabolite provided with antagonist activity on ionotropic
glutamate and α7 nicotinic acetylcholine receptors. We noticed that in rats with a dialysis …

The kynurenine pathway and kynurenine 3-monooxygenase inhibitors

TD Hughes, OF Güner, EC Iradukunda, RS Phillips… - Molecules, 2022 - mdpi.com
Under normal physiological conditions, the kynurenine pathway (KP) plays a critical role in
generating cellular energy and catabolizing tryptophan. Under inflammatory conditions …

Kynurenic acid: a metabolite with multiple actions and multiple targets in brain and periphery

F Moroni, A Cozzi, M Sili, G Mannaioni - Journal of neural transmission, 2012 - Springer
It is usually assumed that kynurenic acid (KYNA) modifies neuronal function because it
antagonizes the glycine site of the NMDA receptors and/or the neuronal cholinergic α7 …